On May 1, Bayer launched the "Test Your Cancer" campaign, which encourages cancer patients to undergo genomic testing to ensure more precise diagnoses and increase their treatment options.
Genomic cancer testing identifies alterations within cells' DNA that can give greater insight into a tumor's function, information that can be used to match patients with approved or investigational treatments. However, according to the pharmaceuticals giant, only 25 percent of cancer patients and caregivers currently discuss genomic cancer testing with a physician.
"Genomic cancer testing allows physicians to create a more individualized treatment plan for the patient based on their cancer," Robert LaCaze, EVP of Bayer's Oncology Strategic Business Unit, said. "During this important time when innovation in cancer treatment is rapidly evolving, Bayer is encouraging genomic cancer testing from the start of a diagnosis, in order to make well-informed treatment decisions based on the patient's cancer."
More articles about health IT:
Scientists use CRISPR gene editing as antidote to box jellyfish stings
Avoid the 'basic cardinal sins of password generation': 3 questions with UC Davis security expert Dr. Jeff Tully
Cerner's chief people officer to retire in June